Markets Daily logo

The Latest Headlines at Markets Daily

Image about Netlist (OTCMKTS:NLST) Shares Gap Up – Should You Buy?

Netlist (OTCMKTS:NLST) Shares Gap Up – Should You Buy?

Netlist, Inc. (OTCMKTS:NLST – Get Free Report)’s stock price gapped up before the market opened on Monday. The stock had previously closed at $5.20, but opened at $5.73. Netlist shares last traded at $6.02, with a volume... More of this article »
Image about Replimune Group (NASDAQ:REPL) Sets New 52-Week High – Here’s Why

Replimune Group (NASDAQ:REPL) Sets New 52-Week High – Here’s Why

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday. The company traded as high as $22.22 and last traded at $22.4440, with a volume of 248,937 shares... More of this article »
Image about Spyglass Pharma (NASDAQ:SGP) Sets New 1-Year High – Still a Buy?

Spyglass Pharma (NASDAQ:SGP) Sets New 1-Year High – Still a Buy?

Spyglass Pharma, Inc. (NASDAQ:SGP – Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as $39.92 and last traded at $37.6840, with a volume of 18,000 shares trading hands. The stock... More of this article »
Image about T-Rex 2X Long NVIDIA Daily Target ETF (BATS:NVDX) Reaches New 12-Month Low – What’s Next?

T-Rex 2X Long NVIDIA Daily Target ETF (BATS:NVDX) Reaches New 12-Month Low – What’s Next?

T-Rex 2X Long NVIDIA Daily Target ETF (BATS:NVDX – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday. The company traded as low as $10.96 and last traded at $12.0190, with a volume of 3,642,656 shares... More of this article »
Image about BILL (NYSE:BILL) Stock Price Target Raised at TD Cowen

BILL (NYSE:BILL) Stock Price Target Raised at TD Cowen

BILL (NYSE:BILL – Get Free Report) had its price objective increased by equities researchers at TD Cowen from $59.00 to $66.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Image about High Liner Foods (TSE:HLF) Hits New 12-Month High – Still a Buy?

High Liner Foods (TSE:HLF) Hits New 12-Month High – Still a Buy?

High Liner Foods Inc (TSE:HLF – Get Free Report)’s share price reached a new 52-week high on Monday. The stock traded as high as C$26.90 and last traded at C$26.84, with a volume of 9,338 shares changing hands. The stock... More of this article »
Image about Primo Brands (NYSE:PRMB) Stock Price Target Raised at Barclays

Primo Brands (NYSE:PRMB) Stock Price Target Raised at Barclays

Primo Brands (NYSE:PRMB – Get Free Report) had its price objective upped by analysts at Barclays from $26.00 to $29.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “overweight”... More of this article »
Image about Data Storage (NASDAQ:DTST) vs. Telecom Argentina Stet – France Telecom (NYSE:TEO) Head to Head Comparison

Data Storage (NASDAQ:DTST) vs. Telecom Argentina Stet – France Telecom (NYSE:TEO) Head to Head Comparison

Data Storage (NASDAQ:DTST – Get Free Report) and Telecom Argentina Stet – France Telecom (NYSE:TEO – Get Free Report) are both communication services companies, but which is the better business? We will contrast the... More of this article »
Image about Head to Head Review: Doximity (DOCS) and Its Rivals

Head to Head Review: Doximity (DOCS) and Its Rivals

Doximity (NYSE:DOCS – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its peers? We will compare Doximity to related businesses based on the strength... More of this article »
Image about CG Oncology (NASDAQ:CGON) Given New $84.00 Price Target at Wedbush

CG Oncology (NASDAQ:CGON) Given New $84.00 Price Target at Wedbush

CG Oncology (NASDAQ:CGON – Free Report) had its target price increased by Wedbush from $80.00 to $84.00 in a report issued on Friday morning,Benzinga reports. Wedbush currently has an outperform rating on the stock. Several other... More of this article »
Image about Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) & Exagen (NASDAQ:XGN) Head-To-Head Review

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) & Exagen (NASDAQ:XGN) Head-To-Head Review

Exagen (NASDAQ:XGN – Get Free Report) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the... More of this article »
Image about Head-To-Head Comparison: KVH Industries (NASDAQ:KVHI) vs. Kyivstar Group (NASDAQ:KYIV)

Head-To-Head Comparison: KVH Industries (NASDAQ:KVHI) vs. Kyivstar Group (NASDAQ:KYIV)

Kyivstar Group (NASDAQ:KYIV – Get Free Report) and KVH Industries (NASDAQ:KVHI – Get Free Report) are both communication services companies, but which is the better business? We will compare the two businesses based on... More of this article »
Image about Lindblad Expeditions (LIND) & Its Peers Head to Head Comparison

Lindblad Expeditions (LIND) & Its Peers Head to Head Comparison

Lindblad Expeditions (NASDAQ:LIND – Get Free Report) is one of 382 publicly-traded companies in the “Hotels, Restaurants & Leisure” industry, but how does it weigh in compared to its rivals? We will compare Lindblad... More of this article »
Image about Live Nation Entertainment (NYSE:LYV) Stock Gets Price Target Cut from JPMorgan Chase & Co.

Live Nation Entertainment (NYSE:LYV) Stock Gets Price Target Cut from JPMorgan Chase & Co.

Live Nation Entertainment (NYSE:LYV – Free Report) had its target price reduced by JPMorgan Chase & Co. from $205.00 to $200.00 in a report issued on Friday morning,Benzinga reports. They currently have an overweight rating... More of this article »
Image about InMed Pharmaceuticals (NASDAQ:INM) Stock Picked Up by Analysts at Guggenheim

InMed Pharmaceuticals (NASDAQ:INM) Stock Picked Up by Analysts at Guggenheim

Research analysts at Guggenheim began coverage on shares of InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) in a research report issued on Monday, Benzinga reports. The firm set a “buy” rating and a $42.00 price... More of this article »